Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21

Abstract Currently, there is no satisfactory treatment for pulmonary fibrosis, and effective agents urgently need to be developed. The aim of the present study was to investigate the effects of baicalein on bleomycin-induced pulmonary fibrosis, and the novel mechanisms involved in the anti-fibrosis...

Full description

Saved in:
Bibliographic Details
Published in:Pulmonary pharmacology & therapeutics 2013-12, Vol.26 (6), p.649-654
Main Authors: Gao, Yan, Lu, Jia, Zhang, Yu, Chen, Yafen, Gu, Zhenlun, Jiang, Xiaogang
Format: Article
Language:English
Subjects:
Actins - metabolism
Administration, Oral
Animals
Antioxidants - metabolism
Baicalein
Bleomycin
Bleomycin - toxicity
Disease Models, Animal
Dose-Response Relationship, Drug
Flavanones - administration & dosage
Flavanones - pharmacology
Hydroxyproline - metabolism
Male
Medical Education
MicroRNAs - antagonists & inhibitors
MiR-21
Pulmonary fibrosis
Pulmonary Fibrosis - drug therapy
Pulmonary Fibrosis - physiopathology
Pulmonary/Respiratory
Rats
Rats, Sprague-Dawley
Signal Transduction - drug effects
Smad2 Protein - metabolism
Smad3 Protein - metabolism
TGF-β/Smad signaling
Transforming Growth Factor beta1 - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Currently, there is no satisfactory treatment for pulmonary fibrosis, and effective agents urgently need to be developed. The aim of the present study was to investigate the effects of baicalein on bleomycin-induced pulmonary fibrosis, and the novel mechanisms involved in the anti-fibrosis effects. Pulmonary fibrosis was induced by a single intratracheal instillation of 5 mg/kg bleomycin. Two bleomycin-treated groups were orally administered daily with 50 and 100 mg/kg of baicalein from day 1 to 28. The results showed baicalein decreased hydroxyproline content and α-SMA levels and increased lung index. Histopathological examinations demonstrated baicalein could obviously lower the degree of alveolitis and lung fibrosis. The total antioxidant capacity in bleomycin-treated rats with baicalein was also remarkably higher than in those without baicalein. Baicalein remarkably decreased miR-21 levels and inhibited the increased expression of TGF-β1 and p-Smad-2/3 in bleomycin-treated rats. Baicalein can attenuate bleomycin-induced pulmonary fibrosis. The attenuation is partly achieved by improving antioxidant activity, alleviating inflammation, repressing miR-21, and inhibiting TGF-β/Smad signaling.
ISSN:1094-5539
1522-9629
DOI:10.1016/j.pupt.2013.03.006